Categories: Market Watch

GBB Drink Labs Initiates $53 Million Lawsuit Against FSD Biosciences Inc. For Trade Secret Misappropriation

Miami, FL, December 5, 2023 — GBB Drink Labs, a leader in innovative beverage solutions, has officially filed a lawsuit against FSD Biosciences Inc. in response to the blatant non-compliance with a Cease-and-Desist letter issued on April 14th, 2023. The lawsuit, formally submitted on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, seeks $53 million in damages for a material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The legal action stems from seven months of collaborative discussions between GBB Drink Labs and FSD Pharma, exploring a business opportunity related to GBB’s groundbreaking blood alcohol detoxification drink. FSD Pharma’s public disclosure of the misappropriation of GBB’s trade secrets, without crucial information, during the launch of a new research and development program has led to the initiation of legal proceedings.

The lawsuit alleges that FSD Pharma not only misused GBB’s proprietary and confidential material to attract capital and renowned entrepreneurs but also artificially inflated the price of FSD Pharma’s publicly traded stock. GBB Drink Labs, responding strongly to these actions, is seeking compensatory and punitive damages, coupled with an injunction to prevent any further unlawful disclosure and use of GBB’s trade secrets.

The case, officially titled GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC., has been assigned case number 0:23-cv-60800-AHS in the U.S. District Court for the Southern District of Florida.

For more information on the case, please visit www.sinkingstocks.com.

About GBB Drink Labs: GBB Drink Labs boasts a patented formula that accelerates the process of converting alcohol to sugar in the body, facilitating rapid blood alcohol detoxification. The company has dedicated years to developing a proprietary drink, culminating in a successful acquisition of its patents by Jupiter Wellness, Inc. The closing date for the acquisition is set for August 11th, 2023, with Jupiter Wellness proudly introducing the world’s first rapid blood alcohol detoxification product, “Safety Shot.”

Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please email at contact@etrendystock.com

BTW

Recent Posts

Arbra Unveils Tokenized Private Equity Basket with SpaceX, Ramp, and Varda on Colb

London, UK, 27th June 2025, Arbra Partners Group (“Arbra”), the global financial services company, has…

15 hours ago

Calyptus Launches New AI Hiring Platform To Close the Global Productivity Gap

London, UK, 27th June 2025, ZEX PR WIRE, Calyptus, the hiring platform known for verifying…

15 hours ago

Unleashing Ghostdriver by Tearline: Browser-Native AI Agent for the Seamless Web2 and Web3 Task Execution

British Virgin Islands, BVI, 26th June 2025, ZEX PR WIRE, In an era where every second…

2 days ago

Bety Casino Raises the Stakes: New VIP Program Delivers Exclusive Crypto Gaming Benefits for High-Value Players

Paranaque City, Philippines, 26th June 2025, ZEX PR WIRE, Bety, the innovative crypto casino and…

2 days ago

CrocCoin Introduces Groundbreaking Meme-to-DeFi Ecosystem on Solana, Featuring Progressive Decentralization

Innovative Project Merges Meme Culture with Institutional Security, Sustainable Tokenomics, and Community Governance Goiânia –…

4 days ago

Sandford Blair Capital Delivers Consistent Growth Through Adaptive Investment Strategies

Lier, Belgium, 23rd June 2025, ZEX PR WIRE, Sandford Blair Capital, a quantitative investment management…

5 days ago